Sort by
Refine Your Search
-
Category
-
Employer
- Biobizkaia Health Research Institute
- FUNDACION DE INVESTIGACION BIOMEDICA HOSPITAL 12 DE OCTUBRE
- Institute for bioengineering of Catalonia, IBEC
- Instituto de Investigación Biomédica de Salamanca (IBSAL)
- IrsiCaixa AIDS Research Institute
- Josep Carreras Leukaemia Research Institute (IJC)
- NANOGETIC
- UNIVERSIDAD CATÓLICA DE MURCIA - FUNDACIÓN UNIVERSITARIA SAN ANTONIO DE MURCIA
-
Field
-
» Cancer research Researcher Profile First Stage Researcher (R1) Country Spain Application Deadline 15 Mar 2024 - 23:59 (Europe/Madrid) Type of Contract Permanent Job Status Full-time Hours Per Week 39 Offer
-
platform against haematological and solid cancers - CAR-NK 2.0" (Ref: 2023111086) of the Biobizkaia Health Research Institute. Requirements Research FieldMedical sciences » Health sciencesEducation LevelPhD
-
and prospects for immunotherapy against relapsed or refractory haematological cancers. Phase I clinical trial to assess the feasibility and safety of allogeneic CD19-CAR-NK therapy for patients with
-
by external magnetic fields. Applications in Cancer Treatment Within the European doctoral network “CoCoGel ” a Ph.D. position is available at Nanogetic in collaboration with the University of Granada
-
UNIVERSIDAD CATÓLICA DE MURCIA - FUNDACIÓN UNIVERSITARIA SAN ANTONIO DE MURCIA | Spain | about 2 months ago
23 Feb 2024 Job Information Organisation/Company UNIVERSIDAD CATÓLICA DE MURCIA - FUNDACIÓN UNIVERSITARIA SAN ANTONIO DE MURCIA Research Field Biological sciences » Biology Medical sciences » Cancer
-
culture and molecular biology techniques in pediatric cancer and exercise research field. 2. Mentoring, supervising and training of personnel. 3. Conception and design of the experiments, including
-
19 Feb 2024 Job Information Organisation/Company Josep Carreras Leukaemia Research Institute (IJC) Research Field Medical sciences » Cancer research Researcher Profile First Stage Researcher (R1
-
will be within the framework of the project SpaceClones, whose objective is to develop high-throughput and spatial perturbation assays to understand on how cancer cell clones spatially organize to drive
-
of experience in biological research (0- 5 points)(b) Experience in cancer and bioinformatics (0- 5 points)c) Publications in biology and bioinformatics (0- 5 points)(d) Expertise in basic and clinical